TRIB

Trinity Biotech

45 hedge funds and large institutions have $72.9M invested in Trinity Biotech in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
Holders Change %
0%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
10
Reduced
14
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
WS
26
Wedbush Securities
California
$83K -$6.89K -276 -8%
RC
27
RBF Capital
California
$75K
Geode Capital Management
28
Geode Capital Management
Massachusetts
$69K +$69K +2,782 New
Verition Fund Management
29
Verition Fund Management
Connecticut
$60K +$60K +2,418 New
US Bancorp
30
US Bancorp
Minnesota
$59K -$44.6K -1,800 -43%
TRCT
31
Tower Research Capital (TRC)
New York
$46K -$4K -159 -8%
Northern Trust
32
Northern Trust
Illinois
$46K +$46K +1,831 New
Acadian Asset Management
33
Acadian Asset Management
Massachusetts
$29K +$29K +1,163 New
ECM
34
Engine Capital Management
New York
$21K
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
$16K
JCM
36
Jacobi Capital Management
Pennsylvania
$10K
WT
37
Whittier Trust
California
$5K
AG
38
Advisor Group
Arizona
$5K
Royal Bank of Canada
39
Royal Bank of Canada
Ontario, Canada
$3K
Bank of America
40
Bank of America
North Carolina
$3K
IA
41
IFP Advisors
Florida
$1K -$1.13K -54 -53%
ASN
42
Advisory Services Network
Georgia
$1K
AP
43
Atwood & Palmer
Missouri
$1K
CSC
44
Cove Street Capital
California
-$473K -18,380 Closed
WAS
45
WESPAC Advisors SoCal
California
-$26K -1,040 Closed
UBS Group
46
UBS Group
Switzerland
-$6K -229 Closed
RE
47
RBC Europe
United Kingdom
-$4.08K -158 Closed